Credit of Final Cash Dividend 2022

The shareholders of GlaxoSmithKline (GSK) Pakistan Limited are hereby informed that the Final Cash Dividend at the rate of Rs. 7.00 per share (i.e. 70% ) for the year ended December 31, 2021, approved by the shareholders of GSK in the 75th Annual General Meeting of the Company, held on 25 April 2022, has been directly credited through electronic mode on May 09, 2022, into the designated bank accounts of those entitled shareholders who have provided their valid Computerized National Identity Cards (CNICs) and valid International Bank Account Number (IBAN) details.

Mandatory Requirement for Provision of IBAN and Valid CNIC
In order to comply with the requirements of Section 242 of the Companies Act 2017 and subsequent notification through SRO 1145(1)/2017 dated November 6, 2017 of SECP, the Company has withheld dividend (D-99) of those shareholders who have still not provided their complete bank details, including IBAN along with copy of valid CNIC.

Accordingly, shareholders are advised to provide a legible and valid copy of CNIC along with complete bank details including 24 digit IBAN, by filling “Form for Dividend Mandate” available at the Company’s website http://www.pk.gsk.com to the Company’s Share Registrar “CDC Share Registrar Services Limited” (in case of shareholding in physical form) & Stock Market Brokers (in case of shareholding in CDS) at earliest, enabling the Company to proceed with electronically credit/payment of cash dividend(s).

Registration on CDC’s e-Services Web Portal
The respective shareholders may access the Centralized Cash Dividend Register (CCDR) developed by CDC via www.eservices.cdcaccess.com.pk/public/ index.xhtml by registering themselves, to obtain status of their cash dividend such as either paid or unpaid, withheld by the Company, total amount of cash dividend, tax and Zakat deductions and net cash credited into their designated bank accounts (IBANs).

Deposit of Physical Shares into CDC Account
Shareholders having physical shareholdings are encouraged to place their physical shares into scripless form as defined in Section 72 (2) of the Companies Act, 2017 i.e., “Every existing company shall be required to replace its physical shares with book-entry form in a manner as may be specified and from the date notified by SECP, within a period not exceeding four years from the commencement of this Act.”

By Order of the Board

Mehar-e-daraksha Ameer
Company Secretary

Karachi
Dated: May 10, 2022